Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad J Reissig

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|September 15, 2019
Does lower brain-derived neurotrophic factor in adolescent waterpipe smokers suggest a negative effect on the developing brain?Elena V Mishina, Chad J Reissig
Biochemical Pharmacology|November 6, 2007
The behavioral pharmacology of hallucinogensWilliam E Fantegrossi, Kevin S Murnane, Chad J Reissig
Drug and Alcohol Dependence|September 24, 2008
Caffeinated energy drinks--a growing problemChad J Reissig, Eric C Strain, Roland R Griffiths
Psychopharmacology|September 10, 2014
Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potentialChad J Reissig, Joseph A Harrison, Lawrence P Carter, et al.
European Journal of Pharmacology|February 12, 2008
d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortexChad J Reissig, Richard A Rabin, Jerrold C Winter, et al.
Psychopharmacology|September 9, 2015
Nicotine reinforcement in never-smokersAngela N Duke, Matthew W Johnson, Chad J Reissig, et al.
Drug and Alcohol Dependence|December 7, 2010
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorumMatthew W Johnson, Katherine A MacLean, Chad J Reissig, et al.
Psychopharmacology|November 9, 2012
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effectsKatherine A MacLean, Matthew W Johnson, Chad J Reissig, et al.
Neuropharmacology|December 1, 2022
Considerations in assessing the abuse potential of psychedelics during drug developmentSilvia N Calderon, Katherine R Bonson, Chad J Reissig, et al.
Psychopharmacology|April 25, 2012
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogensChad J Reissig, Lawrence P Carter, Matthew W Johnson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|September 15, 2019
Does lower brain-derived neurotrophic factor in adolescent waterpipe smokers suggest a negative effect on the developing brain?Elena V Mishina, Chad J Reissig
Biochemical Pharmacology|November 6, 2007
The behavioral pharmacology of hallucinogensWilliam E Fantegrossi, Kevin S Murnane, Chad J Reissig
Drug and Alcohol Dependence|September 24, 2008
Caffeinated energy drinks--a growing problemChad J Reissig, Eric C Strain, Roland R Griffiths
Psychopharmacology|September 10, 2014
Inhaled vs. oral alprazolam: subjective, behavioral and cognitive effects, and modestly increased abuse potentialChad J Reissig, Joseph A Harrison, Lawrence P Carter, et al.
European Journal of Pharmacology|February 12, 2008
d-LSD-induced c-Fos expression occurs in a population of oligodendrocytes in rat prefrontal cortexChad J Reissig, Richard A Rabin, Jerrold C Winter, et al.
Psychopharmacology|September 9, 2015
Nicotine reinforcement in never-smokersAngela N Duke, Matthew W Johnson, Chad J Reissig, et al.
Drug and Alcohol Dependence|December 7, 2010
Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorumMatthew W Johnson, Katherine A MacLean, Chad J Reissig, et al.
Psychopharmacology|November 9, 2012
Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effectsKatherine A MacLean, Matthew W Johnson, Chad J Reissig, et al.
Neuropharmacology|December 1, 2022
Considerations in assessing the abuse potential of psychedelics during drug developmentSilvia N Calderon, Katherine R Bonson, Chad J Reissig, et al.
Psychopharmacology|April 25, 2012
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogensChad J Reissig, Lawrence P Carter, Matthew W Johnson, et al.
Pageof 2